Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$891,300
+$564,348 QoQ
Shares Held
80,515
+88.4% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. REPL ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in REPL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $891,300 | 80,515 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $326,952 | 42,739 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $881,836 | 90,724 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $651,041 | 155,380 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,560,765 | 168,005 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,543,190 | 158,276 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $936,962 | 77,371 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $419,220 | 38,250 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $268,209 | 29,801 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $215,670 | 26,398 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $188,737 | 22,389 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $779,478 | 45,557 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $927,615 | 39,949 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $782,920 | 44,333 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,148 | 79 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,928 | 517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,780 | 960 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $43,994 | 2,591 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $343,870 | 12,689 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $829 | 28 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,075 | 28 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $824,866 | 27,036 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,739,142 | 45,587 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $317,076 | 13,774 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $433,159 | 17,431 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $89,331 | 8,960 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||